local
Atlanta doctors discuss the pros and cons of taking a GLP-1 for weight management
By Laura Scholz at Rough Draft Atlanta (intown neighborhoods)
· July 15, 2026
· 5 min read
It’s impossible to scroll through social media or watch TV without seeing ads for a glucagon-like peptide-1, better known by the acronym GLP-1. Sold under brand names like Ozempic® and Wegovy®, these medications mimic a natural gut hormone that boosts insulin release, slows digestion, and curbs a...
Key takeaway But GLP-1s have also ushered in an era of thinness-chasing, with doctors raising concerns about rapid muscle loss while on the medication and potential misuse by people with eating disorders.
Why this matters in The Atlanta
As Atlantans consider GLP-1 medications for weight management, it's crucial to recognize the potential consequences of relying solely on these drugs. With the city's high rates of obesity and related health issues, it's tempting to seek a quick fix, but doctors like Sharon Bergquist and Alicia Shelly emphasize the importance of supporting medication with lifestyle changes, such as strength training and stress management. This is particularly relevant in Atlanta , where residents often face busy lifestyles and limited access to healthy food options, exacerbating the challenges of maintaining a balanced diet and exercise routine. By acknowledging the complexities of weight loss and the need for a holistic approach, Atlantans can make informed decisions about GLP-1 medications and work towards sustainable, long-term health solutions that benefit the entire community.
About this story
Original reporting by Rough Draft Atlanta (intown neighborhoods) . The Atlanta surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit Rough Draft Atlanta (intown neighborhoods) . Have a tip or correction? Contact our newsroom .
Category: local ·
Published: July 15, 2026 ·
Source: Rough Draft Atlanta (intown neighborhoods) ·
Reading time: 5 min
Get more The Atlanta stories like this
Free weekly briefing covering local and other local news. Curated by our editorial team. No spam.
By subscribing you agree to our privacy policy . Unsubscribe anytime.
Frequently asked about this story
What is this story about? It’s impossible to scroll through social media or watch TV without seeing ads for a glucagon-like peptide-1, better known by the acronym GLP-1. Sold under brand names like Ozempic® and Wegovy®, these medications mimic a natural gut hormone that boosts insulin release, slows digestion, and curbs a...
When was this published? This article was first published on July 15, 2026 by Rough Draft Atlanta (intown neighborhoods) and curated for The Atlanta readers.
Who reported this story? This story was reported by Laura Scholz at Rough Draft Atlanta (intown neighborhoods). To learn more about how The Atlanta selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more local coverage from The Atlanta, or browse our daily briefing and topic hubs .
← Back to all news
More local →
Today’s briefing
Subscribe to newsletter